Return to search results
Eletriptan hydrobromide
Eletriptan Hydrobromide is a generic prescription medication used to treat migraine headaches. It comes as oral tablets in 20 mg and 40 mg strengths, manufactured by Aurobindo Pharma Limited. As a serotonin receptor agonist, it helps relieve migraine symptoms by narrowing blood vessels in the brain. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Eletriptan Hydrobromide is a generic prescription medication used to treat migraine headaches. It comes as oral tablets in 20 mg and 40 mg strengths, manufactured by Aurobindo Pharma Limited. As a serotonin receptor agonist, it helps relieve migraine symptoms by narrowing blood vessels in the brain. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Eletriptan hydrobromide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Eletriptan hydrobromide — ANDA 021016 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021016"
}
]
|
| identifier | ANDA021016 |
| issued | 2016-09-16 |
| keyword |
[
"drug-safety",
"fda",
"health-care",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Eletriptan hydrobromide |
